×
Please click
here
if you are not redirected within a few seconds.
All
Images
News
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
EPO launches modular European Patent Administration Certification (EPAC) to enhance professional development and patent learning | epo.org
epo.org
The European Patent Office (EPO) has introduced a progressive and modular structure for the EPAC, enhancing accessibility and flexibility for professionals...
4 days ago
Interveners Left Out in the Cold: EPO’s G 2/24 Tightens Rules for Late Parties to Patent Challenges
IPWatchdog.com
Interveners Left Out in the Cold: EPO's G 2/24 Tightens Rules for Late Parties to Patent Challenges ... “[Under Decision G 2/24], relying on later...
1 month ago
EPO and UPC align in decision to uphold Edwards Lifesciences’ heart valve patent
JUVE Patent
EPO and UPC align in decision to uphold Edwards Lifesciences' heart valve patent. Following a recent decision of the UPC, the EPO has now also...
3 weeks ago
Epo-calypse now
Science | AAAS
Epo-calypse now: Blocking erythropoietin receptor signaling in macrophages promotes antitumor immunity.
6 months ago
Forebrain-specific loss of erythropoietin provokes compensatory upregulation of different EPO receptors
Nature
The present work has originally been designed to explore consequences of reduced expression of EPO in the forebrain regarding behavior,...
1 month ago
The Enlarged Board of Appeal of the EPO Further Aligns Claim Construction With U.S. and U.K.
Foley Hoag
The Enlarged Board of Appeal of the EPO Further Aligns Claim Construction With U.S. and U.K. ... Key Takeaways: ... Article 69(1) of the EPC states:...
5 months ago
Identification of Hepatic-like EPO as a Cause of Polycythemia
NEJM
Conclusions. We found that secondary erythrocytosis can be related to variants in EPO that lead to the production of hepatic-like EPO with an atypical...
6 months ago
The UPC and EPO Divide: Understanding Conflicting Revocation Proceeding Outcomes
Mintz
No clear legal mechanism currently exists to resolve conflicting outcomes between opposition proceedings before the European Patent Office (EPO) and revocation...
7 months ago
Blocking a surprising master regulator of immunity eradicates liver tumors in mice
Stanford Medicine
Cold” tumors are resistant to common immunotherapies. Stanford Medicine researchers have uncovered a master regulator that can be...
6 months ago
Study shows vital role of public research organisations in European competitiveness
epo.org
Study shows vital role of public research organisations in European competitiveness ... The latest study from the European Patent Office (EPO) Observatory on...
1 month ago